Biotechnology
Viva Biotech Announced 2019 Annual Results
Financial Highlights For the year ended December 31, 2019 * Revenue amounted to approximately RMB323.1 million, representing a significant YOY increase of 53.9% from approximatelyRMB210.0 million in the same period last year. * Gross profit amounted to approximately RMB155.9 million, represe...
2020-03-31 11:45
3914
Innovent Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Progress
SUZHOU, China, March 30, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune, metabolic and oth...
2020-03-31 00:08
4213
Tiger Asia Intelligence Initiates Coverage on AnPac Bio, Ltd
NEW YORK, March 30, 2020 /PRNewswire/ -- Tiger Asia Intelligence has announced it has initiated coverage on AnPac Bio, Ltd (NASDAQ: ANPC). The full report can be found here: AnPac Report Key Report Highlights: AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) is a biotechnology company with op...
2020-03-30 20:30
2685
Fapon Donation Reaches 3 Million PCR Test Components Globally and Welcomes More Participation
DONGGUAN, China, March 30, 2020 /PRNewswire/ -- Fapon Biotech Inc
2020-03-30 20:15
2337
Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device
The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...
2020-03-30 08:00
1991
Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg
TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...
2020-03-27 19:53
3942
C(2) PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment
LUXEMBOURG, March 27, 2020 /PRNewswire/ -- C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In early March,...
2020-03-27 07:33
2560
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius
GOTTINGEN, Germany, March 20, 2020 /PRNewswire/ -- On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction ...
2020-03-20 20:36
9491
AGC Biologics to Participate in Virtual BIO-Europe Spring
AGC Biologics Sponsors 14th Annual BIO-Europe Spring Conference SEATTLE, March 20, 2020 /PRNewswire/ -- AGC Biologics is pleased to be a gold sponsor of BIO-Europe Spring,Europe's largest springtime biotech partnering event. In order to ensure the health of all those participating, the event will...
2020-03-20 03:43
3137
DCAT Week Cancelled, AGC Biologics to Meet Virtually with Industry Leaders
AGC Biologics fosters strong customer partnerships by conducting virtual meetings SEATTLE, March 20, 2020 /PRNewswire/ -- Due to the recent cancellation of DCAT Week,AGC Biologics will be meeting virtually with industry leaders who planned to attend the event. As a Contract Development and Manuf...
2020-03-20 02:44
3005
Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates
SHANGHAI and SAN FRANCISCO, March 19, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), aChina and U.S.-based innovative commercial stage biopharmaceutical company, today announced financial results for the twelve months endedDecember 31, 2019 and corporate updates. "Coinciding with the celeb...
2020-03-20 00:21
4106
Golden Meditech's Associate, Cellenkos, Focuses on the Development of Cell-theray for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)
HONG KONG, March 18, 2020 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise inChina, announced that its associate, Cellenkos, Inc. ("Cellenkos") has submitted a clinical development proposal to the Biomedical ...
2020-03-18 18:16
4426
Beauty Tourism is Causing A Rising Need For Surgical Revisions
SINGAPORE, March 17, 2020 /PRNewswire/ -- Dr. Ivan Puah, Medical Director of Amaris B. Clinic, has noticed a rise in failed results, such as botched procedures in liposuction and gynecomastia surgery, among patients who had their cosmetic procedures done overseas. Dr. Puah, accredited by the M...
2020-03-17 09:30
3040
KUKA Lauded with Frost & Sullivan's Company of the Year Award for Demonstrating Excellence in Growth, Innovation, and Leadership in the Medical Robotics Business
Its extensive product line ranging from small up to heavy payload robots allows it to support customised applications LONDON, March 12, 2020 /PRNewswire/ -- Based on its recent analysis of the global medical robotics market, Frost & Sullivan recognisesKUKA with the 2020 Global Company of the Yea...
2020-03-12 20:00
2121
Bactiguard Launches Product That Protects Against Coronavirus
STOCKHOLM, March 12, 2020 /PRNewswire/ -- Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds. Previous experience shows that the proven effect can be transferred to new variants ...
2020-03-12 15:49
2784
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
3Q20 Added 23,387 New Subscribers Revenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million) Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income Up 56.7% YoY to RMB165.0 Million ($23.7 Million) Conference Call to be Held on March 12, 2020, at 8:00 a.m. ET ...
2020-03-12 04:16
9182
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
DUNDALK, Ireland, March 11, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has completed the weather-tight seal o...
2020-03-11 08:00
2375
Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics
The Opto™ Cell Line Development 2.0 workflow, designed for the Beacon® optofluidic instrument, generates in just days the best production cell lines for complex antibody therapeutics with more than 99% monoclonality assurance EMERYVILLE, Calif., March 10, 2020 /PRNewswire/ -- Today, Berkeley Lig...
2020-03-10 00:00
2420
Pebble Labs and Virbac Announce the Signing of a Comprehensive Commercial Agreement for Aquaculture Disease Prevention
Companies will work to bring RNA-based technologies to global large-scale aquaculture, and focus on a solution for White Spot Syndrome Virus, a disease that can cause 50% crop loss LOS ALAMOS, New Mexico and CARROS, France, March 10, 2020 /PRNewswire/ -- Pebble LabsUSA Inc., a biotechnology comp...
2020-03-09 23:41
3477
Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications
SUZHOU, China and ROCKVILLE, MD., March 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that two clinical studies of...
2020-03-09 20:00
2035
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 306 media titles]
2024-12-19 17:56
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 304 media titles]
2024-12-20 18:11
MediSun Energy Joins the Abu Dhabi Sustainable Finance Declaration, Reinforcing Commitment to Sustainable Solutions in the UAE
[Picked up by 290 media titles]
2024-12-18 15:35
Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
8585
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
8275
